₦airaland Forum

veecovee:
you mean fullbid right

Sorry, full bid. no vex

Sterling full offfer!!!!!!!!!!

debeey87:
Customer access to loans or other financial products based on their stock holding as collateral

The loan is call "Margin loan" of which Meristem also gives. Kindly contact: crmstockbroking@meristemng.com

Locotrader:
Good morning folks.
Transcorp is planning to separate the power subsidiary .How true is this news and what is the effect on share price?
Positive or negative?

Negative

naturalflow:
Nnfm with q2 result alone projecting 5.4 eps selling at 20,instead of you to grab your copy,you were waiting for it to touchdown 14.Even at 30,nnfm is still underpar.we are touching 50!

Safe journey to everyone. Enjoy the gains and pay your tithe

5m?

5m?

I love this arrangement, like monthly salary

emmanuelewumi:
Twice in a year.

Some investors create a bond ladder, which gives them income every month.

January/ July

February/August

March/September

April/October

May/ November

June/December

5m?

ebuka1997:
Insider trading on NGX is too obvious

Wont be surprised if it is the company trying to buy cheap, while they pay those that don't want to sell the final amount.
Very smart strategy.

What is going on with Fidelity bank? Is it preparation for their right issue, that is pushing the price up?

https://ngxgroup.com/exchange/data/corporate-disclosures/
UBA directors mobbing their shares

Why Ur Camry get reverse camera but no screen to show? 2.8m?

5m?

4.2m?

emmanuelewumi:
That is diffusion.


Osmosis is the movement from lower concentration through a semi permeable membrane to areas of higher concentration

Thanks for the correction Prof. Emmauel

Adinije:
Why is gtco price going down while others are going up

It is due to financial "ösmosis", movement of funds from higher concentration to a lower concentrate

Locotrader:
For insurance Lovers, If the market can respond to the Q3 results of Mansard and conerstone insurance, market will also do Justice to Mutual Benefit insurance at just 0.46kobo.Just wait for it.I am just seeing this fantastic result from them.

https://doclib.ngxgroup.com/Financial_NewsDocs/39825_MUTUAL_BENEFITS_ASSURANCE_PLC.-_QUARTER_3_-_FINANCIAL_STATEMENT_FOR_2023_FINANCIAL_STATEMENTS_OCTOBER_2023.pdf

Look at AIICO also.

sterlingD:
DS just dropped
https://doclib.ngxgroup.com/Financial_NewsDocs/39760_DANGOTE_SUGAR_REFINERY_PLC-_QUARTER_3_-_FINANCIAL_STATEMENT_FOR_2023_FINANCIAL_STATEMENTS_OCTOBER_2023.pdf

Loss as expected, this will definately be carried over into DangFood.

sterlingD:
Na to wait and see.l am waiting to see DS result maybe after then they will give us heads-up on the way forward concerning the merger(Just my thoughts)

It will be bad, based on their FX issue like Q2.

ogoo4real:
UCAP

A buy/hold/sell position

All of the above

onegentleguy:
A lot will depend on your entry price and what trade-setup you had in place (plan) in view of your investment personality and objective.

If you've met your target, especially if you were among the early birds (ref: N2 to N6 entry), you might want to reduce your stake by 40-50% and redirect the funds to another more value accretive asset. (we already highlighted some of them here)

I remember advising some folks (privately) to reduce their stake in UCAP and put the funds in UBA/ACCESS (60-40% portfolio weighting in favour of UBA), DS/NASCON, OANDO, WAPCO and CHAMS (still trading at the support/demand zone of 85-90k following the retracement from previous YtDH of N1.3+ at the time)... and I think they've been better off for it.

This is one of the reason I always refer to portfolio weighting with stock selection and fund allocation. The goal should always be to seek to earn more at any given time.

Even with fundamentally healthy coys you don't necessarily need to hold for too long, especially if the asset has achieved/delivered a great reward margin or where the gap between potential return and projected risk has reduced compared to other select healthy names. (ref: assets intrinsic value leaves less MoS compared to CMP)

You can always rebalance your portfolio by allocating some funds to assets that can do better.
UCAP is still trading at a slight deviation from intrinsic value. (ref: FVE @ 21.9) but any jack will agree that there are of course a few better choices right now.

Btw, there are rumors that there could be a potential bonus distribution for YE, 2023, hence my advice to sell only 40-50% of your holding. And depending on the asset price, I will look to exit the balance of 50-60% before or after their YE, 2023 report.
Like I always tell folks; A bonus issue is often a measure that replaces QUALITY with QUANTITY and until you can establish that that quantity is also of good quality, be cautious.
It's like a man who offers to gift you with 3 apples in exchange for the 2 you already have OR buying it off completely for a cash consideration. On the surface, the non-cash exchange might seem of more value but It'll be better to let him buy the 2 you had, if it's of better/healthier quality than the offered 3. ...especially if there's a high plausibility that the said 3 could go bad in days. (near term view)

The wider the margin btw previous OS (quality) and post bonus OS (quantity), the more cautious you should be.

Disclosure: This is just me saying what I would've have done having a stake in UCAP.
NOT an investment advice. Due diligence still applies as always.

Thanks boss.

onegentleguy:
Perhaps you need to dig deeper.

ACCESSCORP is a strong BUY.
Rating now revised to outperform. (previous: hold)

Today's close of N16.85 implies a 79.1% discount from intrinsic value... and that's assuming zero GM in Q4 and raking-off a risk premium equivalent to current surrounding level.
Conservative FVE @ approx N30.2... and believe it when I say that this is me trying to be generously conservative.

Infact I will advise those already in, particularly those who bought at the time we 1st highlighted the coy @ N9-10+ to be overprotective of their stakes.

Whether or not it goes on bid is of little or no consequence. ...it'll even be nice if it can drop in price tomorrow and the day after so the bargaining power of an investor can be much better. (>>MoS/RRM in view)

Again, HOLD!

CAVEAT: Still NOT to be inferred as any sought of recommendation. Due diligence still applies as always.

Welcome back OGG,

What is your take on UCAP?

V4 or V6?

jideflash:
GTB Q3 Result is Out.
Profit After Tax: N367 Billion
Earnings Per Share: N12.98
Current Stock Price: N35
Book Value: N44
Recommendation: ??

Recommendation- Keep watching till January 2024

If UBA is above your reach, I will advise you look at UCAP also

UBA on rampage

ogoo4real:
https://nairametrics.com/2023/10/14/dangote-sugar-refinery-aims-to-boost-production-to-1-5-million-metric-tonnes/

Not a buy/hold recommendations. Due diligence applies...

That is still an assumption, I will wait and see their Q3 and be sure of the loss figure before I jump into their shares. They know how to use news to move their prices.

SOLDDDDD